Amylyx Pharmaceuticals, Inc. Common Stock (NASDAQ: AMLX) last traded at $26.95, down 1.95% on the session. The quote above updates while this page is open; the figures below are drawn from Amylyx Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Amylyx Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker AMLX. Its market capitalisation is $3.00 billion.
Valuation measures for Amylyx Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.00B |
|---|---|
| Enterprise value | $2.98B |
| Price / book | 12.55 |
| Beta | 0.89 |
Trailing-twelve-month figures tagged in Amylyx Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$152.09M |
|---|
| EPS (TTM) | -$1.41 |
|---|
| Return on equity | -63.59% |
|---|
| Cash | $49.33M |
|---|
Range and volume for AMLX over the past 52 weeks.
| 52-week high | $41.14 |
|---|---|
| 52-week low | $10.83 |
| Volume | 762.8K |
| Average volume | 2.31M |
| Previous close | $27.48 |
Invest a chosen dollar amount in Amylyx Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AMLX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.